Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147

Mostrar otras versiones (1)

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the global coronavirus disease 2019 (COVID-19) pandemic, and the search for effective treatments has been limited. Furthermore, the rapid mutations of SARS-CoV-2 have posed challenges to existing vaccines and neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhe, Zhang, Qi, Wu, Xiaoqing, Hao, Siyuan, Hao, Xinbao, Jones, Elizabeth, Zhang, Yuxia, Qiu, Jianming, Xu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377517/
https://www.ncbi.nlm.nih.gov/pubmed/37509657
http://dx.doi.org/10.3390/biomedicines11072019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377517/
https://www.ncbi.nlm.nih.gov/pubmed/37509657
http://dx.doi.org/10.3390/biomedicines11072019

Ejemplares similares